The vaccine candidate was evaluated in Phases I, II and III clinical trials with successful results and has been specifically formulated to allow intranasal delivery through nasal drops, a press release said.
Bharat Biotech’s intranasal vaccine cleared for ‘restricted emergency use for 18+’, efficacy data not released
- Advertisement -
HOT NEWS
No Supreme Court reprieve for Hemant Soren on his arrest by...
No Supreme Court reprieve for Hemant Soren on his arrest by ED
Soren approached the SC against the ED’s action saying that the probe agency abused its powers and acted in a malafide manner to destabilise a democratically elected government in Jharkhand
